Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion via the SIRT2-PGC1α-PPARα pathway, reduces diabetes-induced cardiomyocyte apoptosis, and prevents diabetes-induced cardiac insufficiency (127). Here, MFN2 is linked to diabetes mellitus.